All patients underwent bronchoscopy in the morning on the day after cryoballon ablation. In 1 of 11 (9%) asymptomatic patients, an erythematous lesion (diameter, ≈1.5 cm) with hemorrhagic erosions within the left main bronchus (LMB) near to the left upper lobe was identified via bronchoscopy the next day (patient No. 4; Figure) . The mean distance between the LSPV and the LMB in the overall population was 6.4±2.7 mm. The distance between the LSPV and the LMB was measured during angiography in the anteroposterior position using the PACS measurement tool (Siemens Healthineers, Munich, Germany) when the balloon was fully inflated and contrast agent was injected (Figure) . No patient received a CT scan. In the patient with BI, the distance between the LSPV and LMB was 2.1 mm, and coughing was experienced during the thawing phase after cryoapplication at the LSPV. Coughing was not documented in any other patient during or directly after cryoapplication at the LSPV. Body plethysmography before and after ablation demonstrated no significant differences in vital capacity (3.9±1.2 versus 3.7±1.0 L; P=0.39) and FEV1 (expiratory 1-second capacity; 1.4±0.6 versus 1.4±0.6 L; P=0.5). No major complications occurred during cryoballon ablation or bronchoscopy. All patients were discharged home on the second day. This is the first study that demonstrates BI detected via bronchoscopy the day after PVI using the secondgeneration cryoballon in humans. The LSPV was in closer proximity to the LMB in the patient with BI (2.1 mm) as compared with patients without BI. It appears feasible that the close proximity between the LSPV and LMB could result in a higher likelihood of BI. This observation is in line with the findings of Verma et al. 4 In their study, patients with ice formation within the bronchus during ablation had a closer proximity between LMB and LSPV. In our study the minimal temperature in the patient with BI was −41°C during cryoballon ablation at the LSPV with a maximum duration of 180 seconds of the 2 freezes at the LSPV. It is noteworthy that the patient with BI experienced coughing during the thawing phase after ablation of the LSPV. This may suggest that coughing during cryoapplication or during the thawing phase might be a predictor for BI. The clinical long-term consequences of BI remain unknown yet. However, the results of pulmonary function before and after cryoballon ablation did not differ significantly. The implications of our findings are of major importance for planning larger studies to enhance safety of cryoballon ablation in the future. 
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